UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives

Contraception (Stoneham), 2014-04, Vol.89 (4), p.253-263

2014

Volltextzugriff (PDF)

Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis

Scientific reports, 2021-10, Vol.11 (1), p.20404-20404, Article 20404

2021

Volltextzugriff (PDF)

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study

Gynecological endocrinology, 2023-12, Vol.39 (1), p.2166032-2166032

2023

Volltextzugriff (PDF)

NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study

Gynecological endocrinology, 2023-12, Vol.39 (1), p.2162036-2162036

2023

Volltextzugriff (PDF)

The Menopause Rating Scale (MRS) scale: a methodological review

Health and quality of life outcomes, 2004-09, Vol.2 (1), p.45-45, Article 45

2004

Volltextzugriff (PDF)

The effect of premenstrual symptoms on activities of daily life

Fertility and sterility, 2010-08, Vol.94 (3), p.1059-1064

2010

Volltextzugriff (PDF)

Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives

Obstetrics and gynecology (New York. 1953), 2024-03, Vol.143 (3), p.431

2024

Volltextzugriff (PDF)

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices

Contraception (Stoneham), 2015-04, Vol.91 (4), p.274-279

2015

Volltextzugriff (PDF)

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel

The journal of family planning and reproductive health care, 2011-07, Vol.37 (3), p.132-135

2011

Volltextzugriff (PDF)

Impact of estrogen type on cardiovascular safety of combined oral contraceptives

Contraception (Stoneham), 2016-10, Vol.94 (4), p.328-339

2016

Volltextzugriff (PDF)

Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics-A Systematic Literature Review

BJOG : an international journal of obstetrics and gynaecology, 2024-10

2024

Volltextzugriff (PDF)

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices

Contraception (Stoneham), 2015-04, Vol.91 (4), p.280-283

2015

Volltextzugriff (PDF)

ESTRADIOL IS ASSOCIATED WITH DECREASED CARDIOVASCULAR RISK COMPARED TO ETHINYLESTRADIOL WHEN CONTAINED IN COMBINED HORMONAL PREPARATIONS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW ENDOMETRIOSIS THERAPIES

Fertility and sterility, 2020-09, Vol.114 (3), p.e78-e79

2020

Volltextzugriff (PDF)

COMPARING THE CARDIOVASCULAR RISK OF NORETHINDRONE ACETATE- AND LEVONORGESTREL-CONTAINING ORAL CONTRACEPTIVES: IS THERE A DIFFERENCE?

Fertility and sterility, 2020-09, Vol.114 (3), p.e11-e12

2020

Volltextzugriff (PDF)

Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism

The European journal of contraception & reproductive health care, 2021-12, Vol.26 (6), p.439-446

2021

Volltextzugriff (PDF)

Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across twelve European countries

Contraception (Stoneham), 2024-04, Vol.132, p.110375-110375, Article 110375

2024

Volltextzugriff (PDF)

Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring

Obstetrics and gynecology (New York. 1953), 2013-10, Vol.122 (4), p.800-808

2013

Volltextzugriff (PDF)

Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across 12 European countries

Contraception (Stoneham), 2024-01, p.110375, Article 110375

2024

Volltextzugriff (PDF)

Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives

Contraception (Stoneham), 2016-05, Vol.93 (5), p.378-385

2016

Volltextzugriff (PDF)

Quality of evidence for expulsion rates of copper IUDs

Contraception (Stoneham), 2024-09, p.110707, Article 110707

2024

Volltextzugriff (PDF)

Response to letter to the Editor

Contraception (Stoneham), 2024-08, Vol.136, p.110481, Article 110481

2024

Volltextzugriff (PDF)

Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12

Contraception (Stoneham), 2024-03, p.110444-110444, Article 110444

2024

Volltextzugriff (PDF)

How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?

Contraception (Stoneham), 2023-07, Vol.123, p.110003-110003, Article 110003

2023

Volltextzugriff (PDF)

Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA)

Contraception (Stoneham), 2019-07, Vol.100 (1), p.31-36

2019

Volltextzugriff (PDF)

Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis

Thrombosis and haemostasis, 2024-09

2024

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(91)

Sprache

Englisch
(90)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(39)
Female
(35)
Obstetrics & Gynecology
(30)
Adult
(24)
Prospective Studies
(14)
Middle Aged
(13)
Young Adult
(13)
Adolescent
(11)
Europe
(11)
Levonorgestrel
(11)
Biochemistry & Molecular Biology
(10)
Crystallography, X-Ray
(10)
Bacterial Proteins - Chemistry
(9)
Contraceptives, Oral, Combined - Adverse Effects
(8)
Models, Molecular
(8)
Obstetrics And Gynecology
(8)
Prospective Cohort Study
(8)
Bacterial Proteins - Metabolism
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives

Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study

NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study

The Menopause Rating Scale (MRS) scale: a methodological review

The effect of premenstrual symptoms on activities of daily life

Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices

Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel

Impact of estrogen type on cardiovascular safety of combined oral contraceptives

Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics-A Systematic Literature Review

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices

ESTRADIOL IS ASSOCIATED WITH DECREASED CARDIOVASCULAR RISK COMPARED TO ETHINYLESTRADIOL WHEN CONTAINED IN COMBINED HORMONAL PREPARATIONS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW ENDOMETRIOSIS THERAPIES

COMPARING THE CARDIOVASCULAR RISK OF NORETHINDRONE ACETATE- AND LEVONORGESTREL-CONTAINING ORAL CONTRACEPTIVES: IS THERE A DIFFERENCE?

Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism

Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across twelve European countries

Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring

Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across 12 European countries

Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives

Quality of evidence for expulsion rates of copper IUDs

Response to letter to the Editor

Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12

How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?

Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA)

Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis

Suchergebnisse filtern